Tharimmune Inc (NAS:THAR)

$ 2.08 -0.18 (-7.96%) Market Cap: 3.09 Mil Enterprise Value: 82,000.00 PE Ratio: 0 PB Ratio: 0.89 GF Score: 21/100

Hillstream BioPharma Inc at Sidoti & Company May Micro-Cap Virtual Conference Transcript
May 10, 2023
Hillstream BioPharma Inc to Host Virtual R&D Day Transcript
Feb 14, 2023
Hillstream BioPharma Inc at ThinkEquity Conference Transcript
Oct 26, 2022

Hillstream BioPharma Inc at Sidoti & Company May Micro-Cap Virtual Conference Transcript

May 10, 2023 / 12:30PM GMT

Release Date Price: $159.37 (+0.57%)

Transcript 10-Q10-K/A

Mitra Ramgopal

Sidoti & Company, LLC - Analyst

Okay. Good morning, everyone. My name is Mitra Ramgopal. I'd like to welcome you to the Sidoti Virtual Micro-cap Investor Conference. Our first presenter this morning is CEO Randy Milby from Hillstream BioPharma. As a reminder, the presentation is 30 minutes all in. There will be some time for Q&A at the end. If you have any questions, please type them in the Q&A tab. I'll try to relay as many as possible to Randy.

With that, I'd like to hand it over to Randy Milby.

Randy Milby

Hillstream BioPharma, Inc. - Chairman of the Board, President, & CEO

Thank you. Good morning, everyone. I'm excited to share the Hillstream story with you this morning because we're tackling one of the biggest challenges in cancer treatment today, which is drug resistance. Before I get started, I will be making some forward-looking statements. You can see all of these at the -- on our website and the www.hillstreambio.com.

Our mission

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.